Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer).
Ortmann and Kent et al. show that the order of acquisition of Janus kinase 2 (JAK2) mutations and tet methylcytosine dioxygenase 2 (TET2) mutations in myeloproliferative neoplasms can affect tumour cell biology and clinical phenotypes.